Real-World Study of EGFR-TKIs Combined With Radiotherapy in Patients With Brain Metastases From Non-small Cell Lung Cancer

被引：0
|
作者：
Liu, Yi [1 ]
Zhu, Yaning [1 ]
机构：
[1] Shaanxi Prov peoples Hosp, Dept Oncol, Xian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.06
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study
    Wu, F.
    Wu, S. X.
    Hu, H. C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.
    Wu, Fang
    Wu, Sixuan
    Hu, Chunhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [4] Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US
    Kong, Amanda M.
    Pavilack, Melissa
    Huo, Hairong
    Shenolikar, Rahul
    Moynihan, Meghan
    Marchlewicz, Elizabeth H.
    Chebili-Larson, Christina
    Min, Stella
    Subramaniam, Deepa S.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 328 - 338
  • [5] Efficacy and toxicity of stereotactic radiotherapy combined with third-generation EGFR-TKIs and immunotherapy in patients with brain metastases from non-small cell lung cancer
    Tao, Xiaoxuan
    Gao, Qichang
    Chen, Yiyang
    Cai, Nannan
    Hao, Chuncheng
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [6] Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
    Yu, Xiaoqing
    Sheng, Jiamin
    Pan, Guoqiang
    Fan, Yun
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1121 - 1128
  • [7] Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study
    Shah, Maitri
    Shah, Kashvi
    Dave, Hetvi
    Khadela, Avinash
    Desai, Chirag
    Shah, Sanket
    Shah, Gaurang
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [8] Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis
    He, Mingfeng
    Wu, Xue
    Li, Li
    Yi, Guangming
    Wang, Yitian
    He, Hengqiu
    Ye, Ying
    Zhou, Ruiqin
    Xu, Zaicheng
    Yang, Zhenzhou
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [9] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
    Yu, Xiaoqing
    Si, Jinfei
    Wei, Jingwen
    Wang, Yanling
    Sun, Yan
    Jin, Jianan
    Zhang, Xiaoyan
    Ma, Tonghui
    Song, Zhengbo
    CANCER MEDICINE, 2023, 12 (05): : 5630 - 5638
  • [10] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345